Fangming Wang
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
-
- Renal cell carcinoma treatment 3
- Co-authors
- Nianzeng Xing (11 shared papers)Jianxin Tang (2 shared papers)Guiming Zhang (5 shared papers)Lijiang Sun (5 shared papers)Liyuan Wu (2 shared papers)Yuchun Gu (2 shared papers)Hui Shi (2 shared papers)Feiya Yang (6 shared papers)
- Journals
- Disease Markers (5 papers)Cancer Communications (2 papers)Journal of Cleaner Production (2 papers)Frontiers in Endocrinology (2 papers)Saudi Journal of Biological Sciences (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fangming Wang
31 papers receiving 435 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 73
- Immunology 93
- Oncology 101
- Pulmonary and Respiratory Medicine 63
- Urology 10
Countries citing papers authored by Fangming Wang
This map shows the geographic impact of Fangming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangming Wang more than expected).
Fields of papers citing papers by Fangming Wang
This network shows the impact of papers produced by Fangming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangming Wang. The network helps show where Fangming Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 54 | |
| 2 | 2022 | 50 | |
| 3 | 2022 | 36 | |
| 4 | 2014 | 34 | |
| 5 | 2017 | 30 | |
| 6 | 1997 | 30 | |
| 7 | 2023 | 21 | |
| 8 | 2018 | 18 | |
| 9 | 2024 | 16 | |
| 10 | 2015 | 16 | |
| 11 | 2020 | 15 | |
| 12 | 2019 | 14 | |
| 13 | 2019 | 13 | |
| 14 | 2021 | 12 | |
| 15 | 2022 | 11 | |
| 16 | 2022 | 9 | |
| 17 | 1998 | 8 | |
| 18 | 2017 | 7 | |
| 19 | 2021 | 5 | |
| 20 | 2021 | 5 |
About Fangming Wang
Fangming Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Molecular Biology, having authored 33 papers that have together received 439 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Renal cell carcinoma treatment (3 papers), Immune Cell Function and Interaction (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Immunotherapy and Immune Responses (3 papers), Petri Nets in System Modeling (2 papers), Thermoregulation and physiological responses (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (73 citations), Immunology (93 citations), Oncology (101 citations), Pulmonary and Respiratory Medicine (63 citations) and Urology (10 citations). Fangming Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Nianzeng Xing, Jianxin Tang, Guiming Zhang, Lijiang Sun, Liyuan Wu, Yuchun Gu, Hui Shi, Feiya Yang, Lulin Ma and Xiaojun Tian. Their work appears in journals such as Disease Markers, Cancer Communications, Journal of Cleaner Production, Frontiers in Endocrinology and Saudi Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.